These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7688765)

  • 1. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
    Thigpen AE; Silver RI; Guileyardo JM; Casey ML; McConnell JD; Russell DW
    J Clin Invest; 1993 Aug; 92(2):903-10. PubMed ID: 7688765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the type 1 and 2 steroid 5 alpha-reductases in human fetal tissues.
    Ellsworth K; Harris G
    Biochem Biophys Res Commun; 1995 Oct; 215(2):774-80. PubMed ID: 7488021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and regulation of steroid 5 alpha-reductase 2 in prostate disease.
    Silver RI; Wiley EL; Davis DL; Thigpen AE; Russell DW; McConnell JD
    J Urol; 1994 Aug; 152(2 Pt 1):433-7. PubMed ID: 7516976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulation of steroid 5 alpha-reductase in the urogenital tract of the fetal rat.
    Berman DM; Tian H; Russell DW
    Mol Endocrinol; 1995 Nov; 9(11):1561-70. PubMed ID: 8584033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of steroid 5 alpha-reductase 2 in the human male fetal reproductive tract and adult prostate.
    Levine AC; Wang JP; Ren M; Eliashvili E; Russell DW; Kirschenbaum A
    J Clin Endocrinol Metab; 1996 Jan; 81(1):384-9. PubMed ID: 8550782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5 alpha-reductase expression by prostate cancer cell lines and benign prostatic hyperplasia in vitro.
    Smith CM; Ballard SA; Worman N; Buettner R; Masters JR
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1361-6. PubMed ID: 8636334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization by in situ hybridization of steroid 5alpha-reductase isozyme gene expression in the human prostate and preputial skin.
    Pelletier G; Luu-The V; Huang XF; Lapointe H; Labrie F
    J Urol; 1998 Aug; 160(2):577-82. PubMed ID: 9679931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preputial sebocyte 5alpha-reductase isoform specificity.
    Deplewski D; Liao S; Rosenfield RL
    Endocrinology; 1997 Oct; 138(10):4416-20. PubMed ID: 9322958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type specific expression of steroid 5 alpha-reductase 2.
    Silver RI; Wiley EL; Thigpen AE; Guileyardo JM; McConnell JD; Russell DW
    J Urol; 1994 Aug; 152(2 Pt 1):438-42. PubMed ID: 8015089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural potent androgens: lessons from human genetic models.
    Zhu YS; Katz MD; Imperato-McGinley J
    Baillieres Clin Endocrinol Metab; 1998 Apr; 12(1):83-113. PubMed ID: 9890063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution and kinetic characteristics of rat steroid 5 alpha-reductase isozymes. Evidence for distinct physiological functions.
    Normington K; Russell DW
    J Biol Chem; 1992 Sep; 267(27):19548-54. PubMed ID: 1527072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males.
    Thiele S; Hoppe U; Holterhus PM; Hiort O
    Eur J Endocrinol; 2005 Jun; 152(6):875-80. PubMed ID: 15941927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of 5 alpha-reductase (type 1) messenger ribonucleic acid expression in rat brain: early presence in germinal zones.
    Lauber ME; Lichtensteiger W
    Endocrinology; 1996 Jul; 137(7):2718-30. PubMed ID: 8770891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta).
    Prahalada S; Tarantal AF; Harris GS; Ellsworth KP; Clarke AP; Skiles GL; MacKenzie KI; Kruk LF; Ablin DS; Cukierski MA; Peter CP; vanZwieten MJ; Hendrickx AG
    Teratology; 1997 Feb; 55(2):119-31. PubMed ID: 9143092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of types 1 and 2 5alpha-reductase in human scalp.
    Bayne EK; Flanagan J; Einstein M; Ayala J; Chang B; Azzolina B; Whiting DA; Mumford RA; Thiboutot D; Singer II; Harris G
    Br J Dermatol; 1999 Sep; 141(3):481-91. PubMed ID: 10583052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological and molecular evidence for the expression of the two steroid 5 alpha-reductase isozymes in normal and hyperplastic human prostatic cells in culture.
    Berthaut I; Mestayer C; Portois MC; Cussenot O; Mowszowicz I
    Prostate; 1997 Aug; 32(3):155-63. PubMed ID: 9254894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.
    Godoy A; Kawinski E; Li Y; Oka D; Alexiev B; Azzouni F; Titus MA; Mohler JL
    Prostate; 2011 Jul; 71(10):1033-46. PubMed ID: 21557268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications.
    Wang K; Fan DD; Jin S; Xing NZ; Niu YN
    Asian J Androl; 2014; 16(2):274-9. PubMed ID: 24457841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and differential expression of steroid 5 alpha-reductase type 1 (Srd5a1) and type 2 (Srd5a2) from the Harderian glands of hamsters.
    Ramos L; Chávez B; Vilchis F
    Gen Comp Endocrinol; 2010 Apr; 166(2):388-95. PubMed ID: 20018190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.